These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

592 related items for PubMed ID: 8263622

  • 1. Association of patent ductus arteriosus and phototherapy in infants weighing less than 1000 grams.
    Barefield ES, Dwyer MD, Cassady G.
    J Perinatol; 1993; 13(5):376-80. PubMed ID: 8263622
    [Abstract] [Full Text] [Related]

  • 2. Phototherapy effect on the incidence of patent ductus arteriosus in premature infants: prevention with chest shielding.
    Rosenfeld W, Sadhev S, Brunot V, Jhaveri R, Zabaleta I, Evans HE.
    Pediatrics; 1986 Jul; 78(1):10-4. PubMed ID: 3725477
    [Abstract] [Full Text] [Related]

  • 3. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
    Jaillard S, Larrue B, Rakza T, Magnenant E, Warembourg H, Storme L.
    Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
    [Abstract] [Full Text] [Related]

  • 4. Randomized trial of sterile water by gavage drip in the fluid management of extremely low birth weight infants.
    Stewart CD, Morris BH, Huseby V, Kennedy KA, Moya FR.
    J Perinatol; 2009 Jan; 29(1):26-32. PubMed ID: 18754014
    [Abstract] [Full Text] [Related]

  • 5. Incidence and clinical features of patent ductus arteriosus in low-birthweight infants: a prospective analysis of 150 consecutively born infants.
    Siassi B, Blanco C, Cabal LA, Coran AG.
    Pediatrics; 1976 Mar; 57(3):347-51. PubMed ID: 1256945
    [Abstract] [Full Text] [Related]

  • 6. Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants.
    Mahony L, Carnero V, Brett C, Heymann MA, Clyman RI.
    N Engl J Med; 1982 Mar 04; 306(9):506-10. PubMed ID: 7035955
    [Abstract] [Full Text] [Related]

  • 7. Intrauterine inflammation as a risk factor for persistent ductus arteriosus patency after cyclooxygenase inhibition in extremely low birth weight infants.
    Kim ES, Kim EK, Choi CW, Kim HS, Kim BI, Choi JH, Park JS, Moon KC.
    J Pediatr; 2010 Nov 04; 157(5):745-50.e1. PubMed ID: 20598319
    [Abstract] [Full Text] [Related]

  • 8. The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants.
    Cordero L, Nankervis CA, Gardner D, Giannone PJ.
    J Perinatol; 2007 Jan 04; 27(1):22-7. PubMed ID: 17053778
    [Abstract] [Full Text] [Related]

  • 9. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants.
    Noori S, McCoy M, Friedlich P, Bright B, Gottipati V, Seri I, Sekar K.
    Pediatrics; 2009 Jan 04; 123(1):e138-44. PubMed ID: 19117835
    [Abstract] [Full Text] [Related]

  • 10. Patent ductus arteriosus in African preterm infants.
    Musoke RN, Anabwani GA.
    East Afr Med J; 1991 Aug 04; 68(8):637-41. PubMed ID: 1765017
    [Abstract] [Full Text] [Related]

  • 11. Transcatheter management of patent ductus arteriosus in sick ventilated small infants.
    Kannan BR, Anil SR, Padhi SS, Kumar RK.
    Indian Heart J; 2004 Aug 04; 56(3):232-4. PubMed ID: 15584567
    [Abstract] [Full Text] [Related]

  • 12. Indomethacin prophylaxis for patent ductus arteriosus (PDA) in infants with a birth weight of less than 1250 grams.
    Supapannachart S, Khowsathit P, Patchakapati B.
    J Med Assoc Thai; 1999 Nov 04; 82 Suppl 1():S87-92. PubMed ID: 10730525
    [Abstract] [Full Text] [Related]

  • 13. Total serum bilirubin levels during cyclooxygenase inhibitor treatment for patent ductus arteriosus in preterm infants.
    Rheinlaender C, Helfenstein D, Walch E, Berns M, Obladen M, Koehne P.
    Acta Paediatr; 2009 Jan 04; 98(1):36-42. PubMed ID: 18764861
    [Abstract] [Full Text] [Related]

  • 14. Does Ibuprofen increase neonatal hyperbilirubinemia?
    Zecca E, Romagnoli C, De Carolis MP, Costa S, Marra R, De Luca D.
    Pediatrics; 2009 Aug 04; 124(2):480-4. PubMed ID: 19620202
    [Abstract] [Full Text] [Related]

  • 15. Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants?
    Cordero L, Nankervis CA, Delooze D, Giannone PJ.
    J Perinatol; 2007 Mar 04; 27(3):158-63. PubMed ID: 17251986
    [Abstract] [Full Text] [Related]

  • 16. Outcome of very low birth weight infants exposed to antenatal indomethacin for tocolysis.
    Doyle NM, Gardner MO, Wells L, Qualls C, Papile LA.
    J Perinatol; 2005 May 04; 25(5):336-40. PubMed ID: 15861198
    [Abstract] [Full Text] [Related]

  • 17. Incidence and risk factors associated with the patency of ductus arteriosus in preterm infants with respiratory distress syndrome in Kuwait.
    Hammoud MS, Elsori HA, Hanafi EA, Shalabi AA, Fouda IA, Devarajan LV.
    Saudi Med J; 2003 Sep 04; 24(9):982-5. PubMed ID: 12973483
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phototherapy effect on the incidence of patent ductus arteriosus.
    Pediatrics; 1987 Apr 04; 79(4):653-4. PubMed ID: 3822691
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.